Skip to content

Decision-aid on Breast Cancer Screening

New Invited Women to Breast Cancer Screening: a Multi-centre, Longitudinal, Controlled, Randomised Study on a Decision-aid to Support Informed Choice

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03097653
Enrollment
1001
Registered
2017-03-31
Start date
2017-09-01
Completion date
2019-04-30
Last updated
2021-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

breast cancer screening, mammography, decision-aid, informed choice, National Cancer Screening Program

Brief summary

The present study aim to assess the effect of an interactive web decision aid on informed choice - measured via knowledge, attitudes and intentions concerning breast cancer screening - comparing the decision aid with a standard information provided via web.

Detailed description

Breast cancer is the most common cancer in women. In Italy, women are invited to a population-based mammography screening programme for the first time at the age of 45 or 50 years. Results from randomised controlled trials, observational studies, and systematic reviews continuously fuel the debate on the balance on benefits (reducing breast cancer mortality) and harms (overdiagnosis, overtreatment) of mammography screening. Physicians, policy makers, as well as laypeople or patient associations agree on the need to inform women about the potential benefits and harms in order to allow an aware decision process. Decision aids are an effective way to support lay people in their decisions about health.

Interventions

Web platform with a multilevel information and an aid for the decision to be taken. The content is splitted in 16-20 screens; each screen contains the answer to a common question (i.e. What is mammography screening? What are its benefits and harms? What results can be expected from the participation to mammography screening? What is breast cancer?). The information covers also controversial topics as overdiagnosis, overtreatment and the disagreement among scientists about harms and benefits' quantification.

Web platform with a standard brochure. This standard brochure represents a combination of the best information available from the three participate centre' brochures.

Sponsors

Mario Negri Institute for Pharmacological Research
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 69 Years
Healthy volunteers
Yes

Inclusion criteria

* Women aged 45-69, according to the target age of the screening centres involved; * New invited women in mammography screening programme.

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Adequate Knowledge7-10 daysKnowledge will be measured using a questionnaire structured in 13 questions with multiple choice answers, with 2 to 4 options. Ten questions will be qualitative and 3 will be numerical. A score of 8 out of 13 (about 60%) or higher would be considered adequate knowledge.
Attitude7-10 daysAttitude will be measured through a scale of 6 items with 5 response options from 1 to 5, with a total score from 6 to 30. The investigators set the threshold for a positive attitude at 24 and consequently the score \<24 point a negative attitude.
Intention7-10 daysIntention will be measured using 1 item with 5 responses: Definitely will, Likely to, Unsure, Not likely to, Definitely will not. The investigators classified definitely will and likely to as positive intentions.

Secondary

MeasureTime frameDescription
Number of Times Web Platforms Were AccessedThrough study completion, an average of 10 daysNumber of Times Web Platforms were Accessed assessed trough Pickwick software
Participation Rate to the Breast Cancer Screening Programme15-60 daysParticipation rate to the breast cancer screening programme will be assessed as a percentage of participants who actually participate, both in intervention and in the control group.
Number of Participants With Decisional Conflict Using Decisional Conflict Scale-SURE Version7-10 daysDecisional conflict will be assessed using the validated and widely used Decisional Conflict Scale-SURE version, consisted in four-item scale.
Number of Pages Visited on the Web PlatformsThrough study completion, an average of 10 daysNumber of Pages Visited on the Web Platforms on the web decision aid assessed trough Pickwick software.
Satisfaction With the Information Measured Using 8 Items With Three Points Scale7-10 daysSatisfaction with the given information will be measured using 8 items with three points scale.
Number of Click on the HomepageThrough study completion, an average of 10 daysNumber of click on the Homepage will be assessed trough Pickwick software.

Countries

Italy

Participant flow

Recruitment details

Date of first enrollment: September 2017 Date of last invitation: 31 December 2018 End of study: April 2019

Participants by arm

ArmCount
Decision-aid
Decision-aid: Web platform with a multilevel information and an aid for the decision to be taken. The content is splitted in 16-20 screens; each screen contains the answer to a common question (i.e. What is mammography screening? What are its benefits and harms? What results can be expected from the participation to mammography screening? What is breast cancer?). The information covers also controversial topics as overdiagnosis, overtreatment and the disagreement among scientists about harms and benefits' quantification.
472
Standard Information
Standard information: Web platform with a standard brochure. This standard brochure represents a combination of the best information available from the three participate centre' brochures.
529
Total1,001

Baseline characteristics

CharacteristicDecision-aidStandard InformationTotal
Age, Continuous49.0 years
STANDARD_DEVIATION 3
49.2 years
STANDARD_DEVIATION 3.3
49.1 years
STANDARD_DEVIATION 3.2
Education
Degree
156 participants170 participants326 participants
Education
Elementary
2 participants4 participants6 participants
Education
Higher middle
234 participants272 participants506 participants
Education
Lower middle
69 participants71 participants140 participants
Education
Missing
2 participants3 participants5 participants
Education
Other
9 participants9 participants18 participants
Employment status
Missing
2 participants3 participants5 participants
Employment status
No paid work
104 participants101 participants205 participants
Employment status
Paid work
366 participants425 participants791 participants
Marital status
Married or cohabitant
342 participants386 participants728 participants
Marital status
Missing
2 participants3 participants5 participants
Marital status
Separated or divorced
62 participants73 participants135 participants
Marital status
Unmarried
60 participants61 participants121 participants
Marital status
Widowed
6 participants6 participants12 participants
Race/Ethnicity, Customized
Italian
458 participants506 participants964 participants
Race/Ethnicity, Customized
Missing
2 participants3 participants5 participants
Race/Ethnicity, Customized
Other
12 participants20 participants32 participants
Sex: Female, Male
Female
472 Participants529 Participants1001 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Attitude

Attitude will be measured through a scale of 6 items with 5 response options from 1 to 5, with a total score from 6 to 30. The investigators set the threshold for a positive attitude at 24 and consequently the score \<24 point a negative attitude.

Time frame: 7-10 days

Population: Positive attitude

ArmMeasureValue (NUMBER)
Decision-aidAttitude432 participants
Standard InformationAttitude489 participants
Primary

Intention

Intention will be measured using 1 item with 5 responses: Definitely will, Likely to, Unsure, Not likely to, Definitely will not. The investigators classified definitely will and likely to as positive intentions.

Time frame: 7-10 days

Population: Positive intention

ArmMeasureValue (NUMBER)
Decision-aidIntention460 participants
Standard InformationIntention500 participants
Primary

Number of Participants With Adequate Knowledge

Knowledge will be measured using a questionnaire structured in 13 questions with multiple choice answers, with 2 to 4 options. Ten questions will be qualitative and 3 will be numerical. A score of 8 out of 13 (about 60%) or higher would be considered adequate knowledge.

Time frame: 7-10 days

ArmMeasureValue (NUMBER)
Decision-aidNumber of Participants With Adequate Knowledge236 participants
Standard InformationNumber of Participants With Adequate Knowledge218 participants
Secondary

Number of Click on the Homepage

Number of click on the Homepage will be assessed trough Pickwick software.

Time frame: Through study completion, an average of 10 days

ArmMeasureValue (NUMBER)
Decision-aidNumber of Click on the Homepage514 clicks
Standard InformationNumber of Click on the Homepage334 clicks
Secondary

Number of Pages Visited on the Web Platforms

Number of Pages Visited on the Web Platforms on the web decision aid assessed trough Pickwick software.

Time frame: Through study completion, an average of 10 days

Population: This outcome has been measured only for the interventional arm (Web Decision-aid is splitted in 16-20 screens) because the control arm was just a single webpage.

ArmMeasureValue (MEAN)Dispersion
Decision-aidNumber of Pages Visited on the Web Platforms4.8 Number of pagesStandard Deviation 4.2
Secondary

Number of Participants With Decisional Conflict Using Decisional Conflict Scale-SURE Version

Decisional conflict will be assessed using the validated and widely used Decisional Conflict Scale-SURE version, consisted in four-item scale.

Time frame: 7-10 days

ArmMeasureGroupValue (NUMBER)
Decision-aidNumber of Participants With Decisional Conflict Using Decisional Conflict Scale-SURE VersionDecisional conflict (score ≥3)68 participants
Decision-aidNumber of Participants With Decisional Conflict Using Decisional Conflict Scale-SURE VersionNo decisional conflict404 participants
Standard InformationNumber of Participants With Decisional Conflict Using Decisional Conflict Scale-SURE VersionDecisional conflict (score ≥3)102 participants
Standard InformationNumber of Participants With Decisional Conflict Using Decisional Conflict Scale-SURE VersionNo decisional conflict427 participants
Secondary

Number of Times Web Platforms Were Accessed

Number of Times Web Platforms were Accessed assessed trough Pickwick software

Time frame: Through study completion, an average of 10 days

ArmMeasureValue (MEAN)Dispersion
Decision-aidNumber of Times Web Platforms Were Accessed1.1 number of accessStandard Deviation 0.3
Standard InformationNumber of Times Web Platforms Were Accessed1.0 number of accessStandard Deviation 0.1
Secondary

Participation Rate to the Breast Cancer Screening Programme

Participation rate to the breast cancer screening programme will be assessed as a percentage of participants who actually participate, both in intervention and in the control group.

Time frame: 15-60 days

Population: Participants who had already had a mammogram in the past 6 months were excluded from this dataset.

ArmMeasureValue (NUMBER)
Decision-aidParticipation Rate to the Breast Cancer Screening Programme84.1 percentage of participants
Standard InformationParticipation Rate to the Breast Cancer Screening Programme83.0 percentage of participants
Secondary

Satisfaction With the Information Measured Using 8 Items With Three Points Scale

Satisfaction with the given information will be measured using 8 items with three points scale.

Time frame: 7-10 days

Population: Satisfaction with the information given (intervention and control group) will be measured using 8 items regarding length, quantity, clarity, balance, helpfulness in making decision and women willingness to recommend it to other women with three points scale

ArmMeasureGroupValue (NUMBER)
Decision-aidSatisfaction With the Information Measured Using 8 Items With Three Points ScaleToo much17 participants
Decision-aidSatisfaction With the Information Measured Using 8 Items With Three Points ScaleToo little19 participants
Decision-aidSatisfaction With the Information Measured Using 8 Items With Three Points ScaleFair432 participants
Decision-aidSatisfaction With the Information Measured Using 8 Items With Three Points ScaleMissing4 participants
Standard InformationSatisfaction With the Information Measured Using 8 Items With Three Points ScaleMissing12 participants
Standard InformationSatisfaction With the Information Measured Using 8 Items With Three Points ScaleToo much6 participants
Standard InformationSatisfaction With the Information Measured Using 8 Items With Three Points ScaleFair480 participants
Standard InformationSatisfaction With the Information Measured Using 8 Items With Three Points ScaleToo little31 participants

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026